Dr Nyjon K Eccles BSc MBBS MRCP PhD
If you’ve scrolled through alternative health forums, you’ve likely seen headlines touting the “miracle” cancer cure hiding on the shelves of your local feed store. But the research it has sparked opens a fascinating window into a much broader and more critical conversation for anyone on a cancer journey: the power of metabolic support.
Today, we’re unpacking the some of the science behind a well-known drug, ivermectin, and using it as a springboard to discuss evidence-based adjunctive strategies that can genuinely support a patient’s metabolism and resilience during conventional treatment.
Ivermectin in the Lab: A Potential Multi-Target Agent
First, let’s be unequivocally clear: Ivermectin is not an approved for treatment for cancer in humans. Its established, life-saving role is as an anti-parasitic. However, in petri dishes and animal models, scientists have observed intriguing mechanisms that make it a compound of interest for further research. Understanding these helps illustrate the complex ways we might one day target cancer metabolism.
Here’s what preclinical studies (not human trials) have shown:
- Disrupting Cellular “Shipping”: One of its most studied actions is inhibiting importin proteins, the cell’s nuclear transport drivers. Cancer cells often hijack this system to shuttle pro-growth signals into their nucleus. Ivermectin can jam this traffic, disrupting their growth plans (Wagstaff et al., Biochem J, 2012).
- Turning on Self-Destruct Signals: It can trigger apoptosis (programmed cell death) in cancer cells by activating the mitochondrial pathway and dialling down survival signals like AKT/mTOR (Dogra et al., AIMS Mol Sci, 2018).
- Starving the Tumor: By inhibiting PAK1 kinase, ivermectin may disrupt pathways tumors use for energy and growth, and even target treatment-resistant cancer stem cells (Dou et al., Cancer Res, 2016; Tian et al., Oncol Rep, 2019).
- Cutting Off Supply Lines (Angiogenesis): Some studies note it may reduce factors like VEGF, hindering a tumor’s ability to build new blood vessels for nourishment (Liu et al., Cell Death Discov, 2019).
- Some studies suggest ivermectin can target cancer stem cells, a subpopulation thought to drive tumor initiation, drug resistance, and recurrence.
(Tian et al., Oncology Reports, 2019).
Reaching “lab-effective” doses in humans risks is being investigated in early clinical case studies and trials.
Shifting the Focus: The Paramount Importance of Metabolic Support
The ivermectin story highlights a crucial truth: cancer is a metabolic disease. Tumors rewire their metabolism to fuel rapid growth. This insight brings us to the most actionable part of our discussion: How can patients safely support their own healthy metabolism to improve resilience, treatment tolerance, and potentially outcomes?
This is the world of adjunctive metabolic support—strategies used alongside (not instead of) standard care. Here, the evidence is stronger and directly applicable.
Evidence-Based Pillars of Metabolic Support:
- Dietary Strategy: The Ketogenic Diet (KD)
- The Science: Tumors are often glucose “addicts.” The KD is a high-fat, adequate-protein, very-low-carb diet that shifts the body’s primary fuel from glucose to ketones. Healthy cells adapt to use ketones efficiently, but many cancer cells cannot, potentially creating a “metabolic disadvantage.” Studies also suggest KD may reduce inflammation and oxidative stress.
- The Evidence: A growing body of pilot studies and case reports, particularly in glioblastoma, shows feasibility and hints at potential synergy with radiation and chemotherapy. A key review by Weber et al. (Front Nutr, 2018) outlines its potential as a “therapeutic adjuvant.” It is not a standalone cure, but a strategic dietary intervention that must be medically supervised.
- Pharmacologic Support: Metformin
- The Science: This common diabetes drug lowers blood glucose and insulin levels—two factors that can fuel tumor growth. It activates AMPK, an enzyme that acts as a metabolic master switch, inhibiting the mTOR pathway and potentially slowing cancer cell proliferation.
- The Evidence: Extensive epidemiological data shows reduced cancer incidence and improved outcomes in diabetics taking metformin. It is now the subject of numerous ongoing clinical trials (e.g., NCT02285725) as an adjuvant in cancers like breast and prostate. Its use must be carefully managed to avoid interactions and side effects.
- Lifestyle Foundation: Exercise
- The Science: Exercise is a powerful metabolic modulator. It improves insulin sensitivity, reduces systemic inflammation, and helps regulate hormones like insulin and IGF-1. It also enhances mitochondrial health in healthy tissues.
- The Evidence: The data is robust. The American College of Sports Medicine recommends exercise during and after cancer treatment to reduce fatigue, improve quality of life, and potentially improve survival (Campbell et al., CA Cancer J Clin, 2019). It’s considered a vital part of supportive care.
- Targeted Supplementation (with Caution):
- High-Dose Intravenous Vitamin C (IVC): Unlike oral vitamin C, IVC can achieve high plasma levels that may generate hydrogen peroxide selectively toxic to some cancer cells in lab models. Some early-phase trials suggest potential for improving quality of life and reducing chemotherapy side effects (see review by O’Leary et al., Cancer Treat Rev, 2020). Crucially, it must be administered by a qualified clinic, as it can interact with certain chemotherapies.
The Integrative Takeaway
The journey from a fascinating lab finding (like ivermectin’s) to a safe, effective human therapy is a work in progress. What is becoming more clear is that one empowering step is to focus on the host environment—the body’s metabolism.
Actionable Steps for Patients:
- Anchor to Standard Care: Surgery, chemotherapy, radiation, immunotherapy, and targeted therapy.
- Build a Support Team: Consult with an integrative oncologist or a registered dietitian specializing in oncology to craft a personalized plan.
- Prioritize Evidence-Based Adjuncts: Discuss the role of medical nutrition therapy (like KD), exercise oncology, and other pharmacologic agents like metformin with your team.
The future of oncology lies in smart combination: leveraging powerful conventional tools while strategically supporting the patient’s own biology to create the most hostile environment for cancer and the most resilient one for healing.
Disclaimer: This blog post is for informational purposes only and does not constitute medical advice. It is not an endorsement of ivermectin for cancer treatment. All decisions regarding cancer treatment and adjunctive supportive care should be made in partnership with your medical oncology team.
What Are You Waiting For...
Ask a Question or book a Consultation
If you are interested in learning more about our targeted Metabolic Support Plan fill in the contact form or send your inquiry via email.